During my first year of fellowship, I always found myself interested in the pharmacology of the multiple immunosuppression meds, however, finding concise yet thorough sources of information on them was nearly impossible. Luckily, we have a very fellow…
Introduction: Welcome to the third piece in the Home Hemodialysis series. After going through the history of home hemodialysis in the United States, and reviewing the literature evaluating the modality, we will now dive into how to prescribe…
Introduction Light chain cast nephropathy (LCCN), not to be confused with light chain deposition disease (LCDD), is also known as myeloma cast nephropathy or myeloma kidney; and is one of the many renal complications of multiple myeloma. Patients…
Currently, the timing of initiation of renal replacement therapy (RRT) in critically ill patients with acute kidney injury (AKI) remains a challenge. T Despite several randomized controlled trials (RCTs) comparing early versus late initiation strategies of RRT, the…
This conference, presented by the International Society for Hemodialysis (ISHD), will focus on clinically important topics in hemodialysis, home dialysis, and treatment of CKD/ESKD. The program will work to optimize current practice patterns by providing up-to-date, evidence-based, practical…
Most urinary casts have a fairly homogenous aspect throughout their entirety and are clearly classifiable as either hyaline, granular (with all their variants), waxy, or of some cellular nature. However, in many instances urinary casts are not homogenous…
Last month we focused on introducing the Parasternal Short Axis View (PSAX). Now we turn our attention to some of the must-know abnormalities for the nephrologist in this view. Left ventricular function As mentioned in the previous post,…
Drug related adverse events may not be uncovered until new therapies have been on the market for many years and used among a wider patient population than in the initial clinical trials. Downing and colleagues summarized that, during…
IgA nephropathy (IgAN) is the most common form of glomerulonephritis worldwide, and is responsible for ~10% of glomerulonephritis in the United States. IgA nephropathy can be primary or secondary. The pathophysiology of primary IgAN is complex and incompletely…
The last few decades have been revolutionary in terms of improving end stage kidney disease (ESKD) care with respect to increasing the number of transplant recipients as well as upping the immunosuppression game. The use of calcineurin inhibitors…